Impact of salt substitute and stepwise reduction of salt supply on blood pressure in residents in senior residential facilities: Design and rationale of the DECIDE-Salt trial

Aoming Jin(National Clinical Research Center for Digestive Diseases), Yangfeng Wu(Beijing Haidian Hospital), Qianku Qiao, Pei Gao(Binzhou People's Hospital), Kiang Liu(Northwestern University), Bruce Neal(UNSW Sydney), La’e Cao, Peifen Duan(Changzhi Medical College), Hongxia Wang(Fudan University Shanghai Cancer Center), Jiayu Li(Tongji University), Yuqi Wang(Xi'an Jiaotong University), Huijuan Li(Cleveland Clinic), Ruijuan Zhang(Xi'an Jiaotong University), Hai Fang(King University), Xiangxian Feng(Changzhi Medical College), Hui Zhang(Lanzhou Jiaotong University), Junshi Chen, Darwin R. Labarthe(UK Health Forum)
American Heart Journal
May 30, 2020
10.1016/j.ahj.2020.05.013
Cited by 14

Related Papers

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.8k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k